IVD Raw Materials
The SARS-CoV-2 pandemic necessitated the rapid development of high-quality monoclonal antibodies (mAbs) for therapeutic, diagnostic, and vaccine development.
09-30-2020 Grace Tan, Ph.D. Product Manager, GenScript Reagent Antibody Services
Neoantigen based immuno-oncology therapies are proving promising, but neoantigen identification and production are bottlenecks to boosting efficacy.
09-10-2020 Raymond Miller, Ph.D., GenScript. Julie Rumble Ph.D., Cayman Chemical
If you are struggling with low capture efficiency or high cost to produce your customized panel in targeted sequencing, please come to this FREE webinar to learn about our semiconductor DNA synthesis technologyused for target enrichment, which gives high
08-31-2020 Josh Wang, Ph.D. R&D Sr. Scientist Genscript USA Inc.
In this webinar, you will learn the use of combinatorial DNA libraries, a high-throughput tools, and its applications via case studies.
05-28-2020 Dr. Edward Wong, Field Application Scientist, GenScript
Tips for Successful ELISA kit Development
04-29-2020 Dr. Pei Liu, Senior Scientist, GenScript
Adeno-Associated Viruses (AAVs) have been a prevalent platform for gene delivery due to their simple structure and genome, lack of pathogenicity, and low immunogenicity.
04-22-2020 Susan Butler, Suh Lab, Department of Bioengineering, Rice Universit